Barington/Hilco Acquisition Corp. Rights
BHACR
BHACR was delisted on the 31st of October, 2018.
8 hedge funds and large institutions have $378K invested in Barington/Hilco Acquisition Corp. Rights in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
42% less capital invested
Capital invested by funds: $656K → $378K (-$278K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$6.98K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$1.26K |
BHACR Hedge Fund Activity: Q3 2017 in Review
8 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Barington/Hilco Acquisition Corp. Rights (BHACR) for Q3 2017, worth a combined $378K — down 42% from $656K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BHACR positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $6.98K. The largest seller was Castle Creek Arbitrage, cutting an estimated $1.26K.
- 8 institutional investors held Barington/Hilco Acquisition Corp. Rights (BHACR) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $378K of Barington/Hilco Acquisition Corp. Rights stock for Q3 2017, down 42% quarter-over-quarter.
- 1 fund opened new Barington/Hilco Acquisition Corp. Rights positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest Barington/Hilco Acquisition Corp. Rights buyer in Q3 2017 was Virtu Financial, an estimated $6.98K added.
- The largest Barington/Hilco Acquisition Corp. Rights seller in Q3 2017 was Castle Creek Arbitrage, an estimated $1.26K sold.
Based on aggregated 13F filings for Q3 2017.